LOC105371829: A Potential Drug Target and Biomarker (G105371829)
LOC105371829: A Potential Drug Target and Biomarker
LOC105371829 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its unique expression pattern has led to its potential as a drug target or biomarker. This article will discuss the characterization of LOC105371829, its potential drug targets, and its use as a biomarker in various diseases.
Characterization of LOC105371829
LOC105371829 is a 21-kDa protein that is expressed in the brain, heart, and kidneys. It is predominantly expressed in the brain, where it is found in the peri-synaptic protein complex (PSPC), which includes proteins that are involved in synaptic transmission, such as the neurotransmitter acetylcholine receptor subunit (?±2A).
LOC105371829 is also expressed in the heart, where it is found in the intercellular adhesion molecule 1 (ICAM-1) complex, which is involved in cardiac function and repair. Additionally, LOC105371829 is expressed in the kidneys, where it is found in the glomeruli, which are the sites of proteinuria and other kidney diseases.
Potential Drug Targets
LOC105371829 is a potential drug target due to its unique expression pattern in various tissues. The PSPC, which includes?±2A, is a known drug target for various psychiatric and neurological disorders, including Alzheimer's disease, Parkinson's disease, and chronic pain. The ICAM-1 complex, which is expressed in the heart, is a potential drug target for cardiovascular disease, including heart failure, hypertension, and diabetes. The glomeruli, which are expressed in the kidneys, are a potential drug target for various kidney diseases, including diabetic nephropathy and chronic kidney disease.
LOC105371829 may also be a potential biomarker for various diseases, including neurodegenerative disorders, cardiovascular disease, and chronic kidney disease. Its expression in the PSPC, ICAM-1 complex, and glomeruli suggests that it may be involved in the transmission and regulation of neurotransmitters, which could make it a potential biomarker for neurodegenerative disorders. Additionally, its expression in the heart and kidneys suggests that it may be involved in cardiovascular disease and chronic kidney disease.
Use as a Biomarker
LOC105371829 has the potential to be used as a biomarker for various diseases. Its expression in the PSPC, ICAM-1 complex, and glomeruli suggests that it may be involved in the transmission and regulation of neurotransmitters, which could make it a potential biomarker for neurodegenerative disorders. For example, LOC105371829 may be used as a biomarker for Alzheimer's disease, as its expression is known to be decreased in individuals with Alzheimer's disease compared to healthy individuals.
LOC105371829 may also be used as a biomarker for cardiovascular disease, as its expression is known to be increased in individuals with cardiovascular disease compared to healthy individuals. For example, LOC105371829 may be used as a biomarker for heart failure, as its expression is known to be increased in individuals with heart failure compared to healthy individuals.
LOC105371829 may also be used as a biomarker for chronic kidney disease, as its expression is known to be increased in individuals with chronic kidney disease compared to healthy individuals. For example, LOC105371829 may be used as a biomarker for diabetic nephropathy, as its expression is known to be increased in individuals with diabetic nephropathy compared to healthy individuals.
Conclusion
LOC105371829 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its unique expression pattern has led to its potential as a drug target or biomarker. The PSPC, which includes?±2A, is a known drug target for various psychiatric and neurological disorders, while the ICAM-1 complex, which is expressed in the heart, is a potential drug target for cardiovascular disease. Additionally, the glomeruli, which are expressed in the kidneys, are a potential drug target for various kidney diseases.
LOC105371829 may also be a potential biomarker for neurodegenerative disorders, cardiovascular disease, and chronic kidney disease. Its expression in the PSPC, ICAM-1 complex, and glomeruli suggests that it may be involved in the transmission and regulation of neurotransmitters, which could make it a potential biomarker for neurodegenerative disorders. Additionally, its expression in the heart and kidneys suggests that it may be involved in cardiovascular disease and chronic kidney disease.
With its unique expression pattern, LOC105371829 has the potential to be a valuable drug target or biomarker for various diseases. Further studies are needed to fully understand its role in the body and its potential as a drug or biomarker.
Protein Name: Uncharacterized LOC105371829
The "LOC105371829 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105371829 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105371839 | LOC105371855 | LOC105371870 | LOC105371873 | LOC105371874 | LOC105371887 | LOC105371910 | LOC105371920 | LOC105371956 | LOC105371958 | LOC105371965 | LOC105371967 | LOC105371972 | LOC105372028 | LOC105372046 | LOC105372047 | LOC105372061 | LOC105372093 | LOC105372100 | LOC105372101 | LOC105372112 | LOC105372117 | LOC105372130 | LOC105372131 | LOC105372146 | LOC105372153 | LOC105372155 | LOC105372161 | LOC105372178 | LOC105372185 | LOC105372194 | LOC105372213 | LOC105372221 | LOC105372225 | LOC105372227 | LOC105372283 | LOC105372298 | LOC105372321 | LOC105372326 | LOC105372327 | LOC105372328 | LOC105372343 | LOC105372351 | LOC105372354 | LOC105372371 | LOC105372379 | LOC105372400 | LOC105372401 | LOC105372427 | LOC105372441 | LOC105372460 | LOC105372502 | LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631 | LOC105372639 | LOC105372646 | LOC105372649 | LOC105372664 | LOC105372666 | LOC105372667 | LOC105372669 | LOC105372675 | LOC105372685 | LOC105372687 | LOC105372694 | LOC105372707 | LOC105372710 | LOC105372717 | LOC105372738 | LOC105372745 | LOC105372760 | LOC105372772 | LOC105372787 | LOC105372798 | LOC105372801 | LOC105372802 | LOC105372813 | LOC105372815 | LOC105372832 | LOC105372848 | LOC105372877 | LOC105372881 | LOC105372900 | LOC105372912 | LOC105372932 | LOC105372948 | LOC105372969
